Melatonin Bluefish (Melatonin)

Melatonin binds to MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus, mimicking the body’s natural night‑time hormone. This signaling reduces neuronal activity that promotes wakefulness, facilitating the onset of sleep and helping to synchronize the internal clock with external light‑dark cycles.

The appropriate dose of Melatonin Bluefish is determined by the prescribing clinician based on the patient’s age, condition, and response. Healthcare professionals set the regimen, and patients should follow the specific instructions provided by their prescriber.

Safety data for melatonin use in pregnancy and lactation are limited. It is generally advised that pregnant or breastfeeding individuals discuss potential risks with their healthcare provider before starting melatonin therapy.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Unlike many prescription hypnotics that act on GABA receptors, melatonin works by restoring the natural hormonal signal that regulates circadian rhythms. This mechanism generally results in fewer cognitive side effects, but efficacy may be modest for severe insomnia, where stronger agents might be preferred.

Melatonin Bluefish should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain potency.

The product is formulated for oral administration. Patients typically swallow the tablet or capsule with a glass of water, preferably 30‑60 minutes before bedtime, unless the prescriber advises a different timing.

Serious but rare risks include severe allergic reactions such as rash, swelling, or Stevens‑Johnson syndrome, as well as significant mood changes like depression or hallucinations. Any sudden or severe symptoms should prompt immediate medical evaluation.

Melatonin should be avoided in individuals with known hypersensitivity to melatonin, in children unless specifically prescribed, and in patients taking medications that have major interactions (e.g., strong CYP1A2 inhibitors or anticoagulants) without appropriate medical supervision.